BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
Source: prnewswire.com